Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Subtypes of Neuroendocrine Carcinoma: From Chaos to Consensus. | Annu Rev Pathol | 2026 | 41061171 | PubTator, text mining | PubMed |
| Comprehensive molecular profiling of combined hepatocellular carcinoma and cholangiocarcinoma reveals distinct Notch signaling subgroups with prognostic significance. | Virchows Arch | 2026 | 40637792 | PubTator, text mining | PubMed |
| Conversion of human glial cells into neurons in ex vivo culture of human brain tissue: Essential roles of the transcription factors NeuroD1 and Ascl1. | Neural Regen Res | 2026 | 39665825 | PubTator, text mining | PubMed |
| Grafts of hydrogel-embedded electrically stimulated subventricular stem cells into the stroke cavity improves functional recovery of mice. | Neural Regen Res | 2026 | 39589177 | PubTator, text mining | PubMed |
| Mechanisms and Therapeutic Strategies to Overcome Enzalutamide Resistance in Advanced Prostate Cancer. | Serican J Med | 2025 | 42327601 | PubTator, text mining | PubMed |
| A Hierarchy of Luminal Transcription Factors Defines AR Cistrome and Is Lost in Neuroendocrine Prostate Cancer. | Cancer Heterog Plast | 2025 | 41768226 | PubTator, text mining | PubMed |
| Therapeutic targeting of Aurora Kinase A in advanced prostate cancer. | Serican J Med | 2025 | 41658018 | PubTator, text mining | PubMed |
| The Olive Phenolic S-(-)-Hydroxyoleocanthal Attenuates Neuroendocrine Prostate Cancer via Modulation of EPHA3-Centered Oncogenic Network. | Cancers (Basel) | 2025 | 41514539 | PubTator, text mining | PubMed |
| Extracellular matrix regulates lineage plasticity in prostate cancer through YAP/TEAD. | bioRxiv | 2025 | 41509338 | PubTator, text mining | PubMed |
| A MYC Family Switch: L-MYC Drives and Maintains Neuroendocrine Lineage Programs in Prostate Cancer. | bioRxiv | 2025 | 41509233 | PubTator, text mining | PubMed |
| Prognostic utility of baseline ASCL1/INSM1 expression and neutrophil-lymphocyte ratio in unresectable SCLC treated with first-line chemoimmunotherapy with or without radiotherapy. | Front Med | 2025 | 41454081 | PubTator, text mining | PubMed |
| CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized level. | bioRxiv | 2025 | 41446220 | PubTator, text mining | PubMed |
| Studies of the motifs that regulate subcellular localization reveal differences between the homologous neuronal proteins NeuroD1 and NeuroD2. | Cell Commun Signal | 2025 | 41382210 | PubTator, text mining | PubMed |
| Identifying key regulators in neuronal transdifferentiation by gene regulatory network analysis. | PNAS Nexus | 2025 | 41341622 | PubTator, text mining | PubMed |
| Ascl1 in Retinal Regeneration: From Neuronal Fate Determination to Reprogramming Mechanisms. | FASEB J | 2025 | 41306030 | PubTator, text mining | PubMed |
| Transcription Factor-Based Differentiation of Pluripotent Stem Cells: Overcoming the Traps of Random Neuronal Fate. | Biomedicines | 2025 | 41301876 | PubTator, text mining | PubMed |
| A conserved differentiation programme facilitates inhibitory neuron production in the developing mouse and human cerebellum. | Development | 2025 | 41287940 | PubTator, text mining | PubMed |
| Rapid generation of ventral A9-like dopaminergic neurons from patterned iPSCs. | bioRxiv | 2025 | 41279649 | PubTator, text mining | PubMed |
| GLP1 receptor agonism alters growth and therapeutic response in prostate cancer. | Endocr Relat Cancer | 2025 | 41257454 | PubTator, text mining | PubMed |
| Circadian regulator REV-ERBα is a master regulator of tumor lineage plasticity and an effective therapeutic target. | Proc Natl Acad Sci U S A | 2025 | 41231955 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=8